The global end stage renal disease drugs market is anticipated to grow at a significant CAGR during the forecast period. End stage kidney disease, also known as the late-stage renal disease, refers to a medical condition when chronic kidney disease reaches an advanced or its last stage. In this disease, the kidneys fail to work, as they otherwise function in order to meet the body’s needs. The market growth for their drugs is majorly attributed to the growing number of patients suffering from kidney failure, all over the globe. Factors that increase the risk of end stage renal disease include smoking, hypertension, diabetes, and the geriatric population. In fact, the most common factor includes diabetes, whereas hypertension (high blood pressure) is considered to be the second most frequent cause of this disease.
According to the National Kidney Foundation (NKD), approximately 10% of the global population suffers from chronic kidney diseases and millions die each year. As per the same source, the geriatric population suffers the condition most in emerging economies such as China and India. The number of patients continues to increase at a rate of 5-7% per year. Chronic kidney disease is estimated to be more common in women than men (15% vs 12%). Adding to this, the constantly growing number of patients suffering from hypertension and diabetes are also likely to fuel the end stage renal disease drugs market growth. As per the World Health Organization (WHO), in 2019, around 1.13 billion people globally had hypertension. Adding to this, from 2014-2016, hypertension and diabetes were responsible for nearly 75% of the global kidney failure cases.
To Request a Sample of our Report on End Stage Renal Disease Drugs Market: https://www.omrglobal.com/request-sample/end-stage-renal-disease-drugs-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Novartis International AG, and Eli Lilly and Co., among others.
A full Report of End Stage Renal Disease Drugs Market is Available @ https://www.omrglobal.com/industry-reports/end-stage-renal-disease-drugs-market
End Stage Renal Disease Drugs Market Report by Segment
By Type
- Calcium Succinate
- Mk-3866
- Sanguinate
- Pacritinib
- Others
By Application
- Hospitals
- Clinics
- Research Institutes
End Stage Renal Disease Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
